Beyond Air, Inc. Marketable Securities, Gain (Loss)
Beyond Air, Inc. (XAIR) reported Marketable Securities, Gain (Loss) of $2.08 million for the 12-month period ending 2020-03-31, per its 10-K filed 2021-06-10.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLoss · last filed 2021-06-10
- Beyond Air, Inc. marketable securities, gain (loss) for the quarter ending 2020-03-31 was $3.93M.
- Beyond Air, Inc. marketable securities, gain (loss) for the quarter ending 2019-12-31 was $314.90K, a 1626.99% increase year-over-year.
- Beyond Air, Inc. marketable securities, gain (loss) for the quarter ending 2018-12-31 was $18.23K.
- Beyond Air, Inc. marketable securities, gain (loss) for fiscal 2020 was $2.08M.
| Period end | Marketable Securities, Gain (Loss) 3 month | Marketable Securities, Gain (Loss) 6 month | Marketable Securities, Gain (Loss) 9 month | Marketable Securities, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2020-03-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-10 | $4.24M derived: sum of 2 quarters · filed 2021-06-10 | $2.08M 10-K · filed 2021-06-10 | |
| 2019-12-31 | $314.90K 10-Q · filed 2020-02-07 | -$1.85M 10-Q · filed 2020-02-07 | ||
| 2018-12-31 | $18.23K 10-Q · filed 2020-02-07 | $13.14K 10-Q · filed 2020-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |